Fig. 4From: The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysisSubgroup analysis based on Assay type of sensitivity (a), specificity (b), positive likelihood ratios (c) and negative likelihood ratios (d) for miR-155 by SYBR in the diagnosis of lung cancerBack to article page